Rocket Pharmaceuticals (RCKT) Tops Q3 EPS by 4c

Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q3 EPS of ($0.71), $0.04 better than the analyst estimate of ($0.75).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.

You May Also Be Interested In

• Starlink, AI Capex, rockets: deep dive into SpaceX’s first ever public report
• Eli Lilly & Co. (LLY) call put ratio 1 call to 1.5 puts with into quarter results
• Circle split as Morgan Stanley cuts to Underweight, TD Cowen starts at Buy